Last close As at 05/08/2026
GBP19.16
▲ 28.00 (1.48%)
Market capitalisation
GBP572m
Avon Rubber’s Capital Markets Day highlighted the strength and depth of its product portfolio. Investment in both divisions has ensured that the company is able to address strong growth trends in its end-markets with attractive solutions. Avon Protection has received US regulatory approval for its Powered Air Purifying Respirator range, which should see further orders. Meanwhile, milkrite I InterPuls is offering solutions for productivity improvements to a dairy market increasingly open to technology.
Written by
Avon Rubber |
Equipped for growth |
Capital markets day |
Aerospace & defence |
15 March 2018 |
Share price performance
Business description
Next events
Analysts
Avon Rubber is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||
Avon Rubber’s Capital Markets Day highlighted the strength and depth of its product portfolio. Investment in both divisions has ensured that the company is able to address strong growth trends in its end-markets with attractive solutions. Avon Protection has received US regulatory approval for its Powered Air Purifying Respirator range, which should see further orders. Meanwhile, milkrite I InterPuls is offering solutions for productivity improvements to a dairy market increasingly open to technology.
Year end |
Revenue (£m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
09/16 |
142.9 |
20.7 |
70.5 |
9.5 |
17.1 |
0.8 |
09/17 |
163.2 |
25.6 |
82.3 |
12.3 |
14.7 |
1.0 |
09/18e |
163.2 |
26.4 |
74.5 |
16.0 |
16.2 |
1.3 |
09/19e |
169.2 |
28.1 |
74.7 |
20.8 |
16.1 |
1.7 |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Avon Protection addressing future threats
Avon Protection has developed its product range to not only significantly widen its addressable market but also to increase the sophistication and unit price point of its products. Avon may be selling the same number of units as before to a customer, but the higher unit contribution has a positive multiplier effect. Avon aims to introduce customers to its products and presents them with the opportunity to move up the product suite as demands arise. This also involves working closely with some customers to develop the best solution, which was the case with the Powered Air Purifying Respirator range. After recent regulatory approval, the first US customer for the range is a large federal law enforcement agency, which was involved in the development of the technology. Avon anticipates further orders from US customers in the near future.
milkrite I InterPuls driving productivity
milkrite I InterPuls provides solutions to farmers to address the multiple issues of milk quality, environmental impact, farm efficiency and profitability. The market backdrop is supportive, with rising global consumption of dairy products. As little as 15 years ago, farmers had to be convinced of the benefits of technology, whereas today they are asking what solutions are on offer. The division is scheduled to spend £1.5m on product development this year to ensure they are at the forefront of this evolution.
Valuation: Strategy still supports premium
Our DCF valuation on a calculated WACC of 8.0% currently delivers a value of 1,297p. On 16.2x 2018e P/E, the stock is trading at a discount to its UK aerospace and defence peer group. However, the company’s growth strategy, higher-than-industry-average profitability and building order book afford Avon Rubber the opportunity to deliver further medium-term upside earnings potential and hence justify a valuation premium, in our view.
Capital Markets Day
The London-based event started with an introductory presentation from CEO Paul McDonald. The four key objectives for the event were:
■
clearly illustrate the market drivers for Avon Protection and milkrite I InterPuls
■
demonstrate the importance of innovation to meeting customer needs
■
showcase the breadth and added value within the product range
■
establish the importance of technology in delivering Avon’s strategic objectives
A presentation and product demonstration for each division then followed in smaller groups.
Avon Protection
The table below captures the breadth of the current Avon Protection military portfolio. The suite has developed considerably over the last decade, such that in 2008 the company only offered the M50, FM53 and ST53 products. Today’s portfolio enables customers to be introduced via entry level products and in time move to more sophisticated options as appropriate. A visible benefit here is the step up in unit value, where Avon may be selling the same number of units as before to a customer but the higher unit contribution has a positive multiplier effect. The company’s decision to invest in selective product development is bearing fruit while now addressing a significantly larger market. In addition, with 20- to 30-year product lifecycles, it is important to ensure the product economics from the outset.
Exhibit 1: Avon Protection military portfolio applications 2018
Applications |
M50 |
FM53 |
ST53 |
M53A1 |
FM54 |
ST53SD |
MCM100 |
MDC150 |
EZAIR |
MP-PAPR |
CS-PAPR |
CS-ELITE |
Military operations |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
Counter narcotics operations |
X |
X |
X |
X |
X |
X |
X |
X |
||||
Special operations |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
||
Law enforcement operations |
X |
X |
X |
X |
X |
X |
X |
X |
||||
First responders |
X |
X |
X |
X |
X |
X |
X |
X |
X |
|||
Critical national infrastructure protection |
X |
|||||||||||
Other |
X |
X |
Source: Avon Rubber
An exciting recent development is approval from the National Institute for Occupational Safety and Health in North America of the Powered Air Purifying Respirator range. The first US customer here is a large federal law enforcement agency, which itself was involved in the development of the technology. Avon anticipates further orders from US customers in the near future.
The presentation included a discussion on ‘future threats’ by chemical weapons expert Hamish de Bretton-Gordon. Including recent events in Salisbury, UK, 2018 has already witnessed the most frequent use of chemical weapons since the First World War. De Bretton-Gordon is the chemical, biological, radiological and nuclear adviser to the UK Ministry of Defence and he believes that the current events will affect the UK for the next 10 to 15 years. This increased threat coincides with underinvestment in this area over recent years, leaving military and first responders unprepared. Both the London Fire Brigade Commissioner Dany Cotton and the UK security minister Ben Wallace have stated publicly that a chemical weapon attack on London and the UK, respectively, is a significant and real concern to them. With personnel protection paramount, it is clear that Avon has the optimal portfolio to address the current threat.
milkrite I InterPuls
The milkrite I InterPuls presentation and product demonstration was focused on the dairy farm of the future, addressing the multiple issues of milk quality, environmental impact, farm efficiency and profitability. The market backdrop is supportive, with global consumption of dairy products expected to increase by 25% between 2015 and 2024. Milk production has been steadily growing at 2.3% on average every year since 2000 and the industry employs around 750 million people globally.
milkrite I InterPuls believes that driving operating efficiency with technology is the answer. So, it is less the Internet of Things, and rather the Internet of Cows. Milking cows within the most efficient time window is increasingly important, avoiding the estimated loss of £5 per day that occurs 300 days after calving. Tagging, tracking and monitoring cows permits a number of activities and actions to be monitored. Injured or ill cows can be quickly identified and separated for treatment. Feeding patterns can be analysed in addition to the optimal time for insemination, which is central to milking efficiency and profitability.
milkrite I InterPuls delivers solutions to farming customers, and its customers can be its best advertisement. We were shown an example of a Russian farmer who visited a farm in Italy that was using a milkrite I InterPuls system. Adopting a similar system at his own farm drove production up by 25% in just 12 months.
milkrite I InterPuls offers solutions with world-class products of its own in liners and pulsation equipment. This gives a strong installed base from which to leverage. In addition, we had greater detail on the leasing approach (Exchange) offered to farmers to reduce the time they have to change liners but also improve the regularity of changes. Typically, farmers will leave liners unchanged for longer than is advised, increasing the chance of damage and subsequent infection.
Overall, the market dynamic is changing in milkrite I InterPuls’ favour. As little as 15 years ago, farmers had to be convinced of the benefits of technology, whereas today they are asking what solutions are on offer. The division is scheduled to spend £1.5m on product development this year to ensure they are at the forefront of this evolution.
Exhibit 2: Financial summary
£000s |
2016 |
2017 |
2018e |
2019e |
||
Year end 30 September |
IFRS |
IFRS |
IFRS |
IFRS |
||
PROFIT & LOSS |
||||||
Revenue |
|
|
142,884 |
163,200 |
163,226 |
169,153 |
Cost of Sales |
(90,159) |
(101,500) |
(101,516) |
(105,202) |
||
Gross Profit |
52,725 |
61,700 |
61,710 |
63,950 |
||
EBITDA |
|
|
29,922 |
36,000 |
36,270 |
38,064 |
Operating Profit (before amort. and except.) |
|
|
24,031 |
30,000 |
30,024 |
31,819 |
Intangible Amortisation |
(3,154) |
(4,200) |
(3,372) |
(3,300) |
||
Exceptionals |
(4,808) |
(7,100) |
(4,002) |
(4,004) |
||
Other |
(33) |
(35) |
(36) |
(38) |
||
Operating Profit |
16,036 |
18,665 |
22,613 |
24,476 |
||
Net Interest |
(154) |
(200) |
(171) |
(406) |
||
Profit Before Tax (norm) |
|
|
20,690 |
25,565 |
26,444 |
28,073 |
Profit Before Tax (FRS 3) |
|
|
15,882 |
18,465 |
22,443 |
24,070 |
Tax |
1,824 |
2,900 |
(3,147) |
(4,581) |
||
Profit After Tax (norm) |
21,765 |
25,200 |
22,742 |
22,739 |
||
Profit After Tax (FRS 3) |
17,706 |
21,365 |
19,296 |
19,489 |
||
Average Number of Shares Outstanding (m) |
30.3 |
30.4 |
30.3 |
30.2 |
||
EPS - normalised (p) |
|
|
70.5 |
82.3 |
74.5 |
74.7 |
EPS - (IFRS) (p) |
|
|
58.5 |
70.2 |
63.6 |
64.5 |
Dividend per share (p) |
9.5 |
12.3 |
16.0 |
20.8 |
||
Gross Margin (%) |
36.9 |
37.8 |
37.8 |
37.8 |
||
EBITDA Margin (%) |
20.9 |
22.1 |
22.2 |
22.5 |
||
Operating Margin (before GW and except.) (%) |
16.8 |
18.4 |
18.4 |
18.8 |
||
BALANCE SHEET |
||||||
Fixed Assets |
|
|
77,469 |
66,700 |
63,087 |
56,557 |
Intangible Assets |
47,357 |
40,400 |
36,928 |
33,634 |
||
Tangible Assets |
30,112 |
26,300 |
26,158 |
22,924 |
||
Investments |
0 |
0 |
0 |
0 |
||
Current Assets |
|
|
52,886 |
80,500 |
97,015 |
120,907 |
Stocks |
20,648 |
21,800 |
22,022 |
23,049 |
||
Debtors |
19,968 |
23,800 |
23,804 |
24,668 |
||
Cash |
4,495 |
26,500 |
42,990 |
64,990 |
||
Other |
7,775 |
8,400 |
8,200 |
8,200 |
||
Current Liabilities |
|
|
(36,641) |
(39,000) |
(38,466) |
(43,652) |
Creditors |
(34,142) |
(37,200) |
(36,905) |
(37,936) |
||
Short term borrowings |
(2,499) |
(1,800) |
(1,561) |
(5,716) |
||
Long Term Liabilities |
|
|
(51,713) |
(52,600) |
(52,558) |
(52,516) |
Long term borrowings |
0 |
0 |
0 |
0 |
||
Other long term liabilities |
(51,713) |
(52,600) |
(52,558) |
(52,516) |
||
Net Assets |
|
|
42,001 |
55,600 |
69,078 |
81,296 |
CASH FLOW |
||||||
Operating Cash Flow |
|
|
30,504 |
29,754 |
34,199 |
34,952 |
Net Interest |
(147) |
(154) |
(200) |
(171) |
||
Tax |
(17) |
2,900 |
(3,147) |
(4,581) |
||
Capex |
(6,838) |
(5,500) |
(9,005) |
(6,017) |
||
Acquisitions/disposals |
(3,300) |
0 |
0 |
0 |
||
Financing |
(1,812) |
(1,000) |
(1,000) |
(1,000) |
||
Dividends |
(2,430) |
(3,200) |
(4,118) |
(5,339) |
||
Other |
(803) |
(96) |
0 |
0 |
||
Net Cash Flow |
15,157 |
22,704 |
16,729 |
17,845 |
||
Opening net debt/(cash) |
|
|
13,161 |
(1,996) |
(24,700) |
(41,429) |
HP finance leases initiated |
0 |
0 |
0 |
0 |
||
Other |
0 |
0 |
0 |
(0) |
||
Closing net debt/(cash) |
|
|
(1,996) |
(24,700) |
(41,429) |
(59,274) |
Source: Avon Rubber accounts, Edison Investment Research
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Pty Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com DISCLAIMER |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 295 Madison Avenue, 18th Floor 10017, New York US |
Sydney+61 (0)2 8249 8342 Level 12, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 295 Madison Avenue, 18th Floor 10017, New York US |
Sydney+61 (0)2 8249 8342 Level 12, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
Research: TMT
1Spatial’s trading update flags that group performance is expected to be in line with expectations. The core GIS business traded better than expected at both the revenue and EBITDA levels, but a deterioration in prospects for the non-core Enables business has prompted a disposal of 80.1% of this business to management for a £1. While the low consideration is underwhelming, our investment case has always been predicated on the growth and recovery prospects for GIS. It is encouraging that GIS performance is tracking ahead and greater focus on this business should support both prospects and the investment case.